The company intends to use the funds to expand operations and its business reach.
Founded in 2021 by Red Cell Partners, an investment and incubation firm that backs, builds, and scales technology-led companies in the healthcare and national security sectors and led by CEO David L. Morgan, and Executive Chairman Grant Verstandig, Zephyr AI is a healthcare technology company, which is committed to innovating traditional approaches to drug discovery and precision medicine. Through partnerships and proprietary data, the company is curating a comprehensive healthcare dataset and combining it with artificial intelligence algorithms to generate novel, translatable insights to build tools and products that support both patients and providers and accelerate ongoing research to innovate the treatment of cancer, diabetes, and other diseases.
31/03/2022
